[go: up one dir, main page]

ATE137976T1 - METHOD FOR PURIFYING A 69000 DALTON ANTIGENIC PROTEIN FROM BORDETELLA PERTUSSIS - Google Patents

METHOD FOR PURIFYING A 69000 DALTON ANTIGENIC PROTEIN FROM BORDETELLA PERTUSSIS

Info

Publication number
ATE137976T1
ATE137976T1 AT90120662T AT90120662T ATE137976T1 AT E137976 T1 ATE137976 T1 AT E137976T1 AT 90120662 T AT90120662 T AT 90120662T AT 90120662 T AT90120662 T AT 90120662T AT E137976 T1 ATE137976 T1 AT E137976T1
Authority
AT
Austria
Prior art keywords
bordetella pertussis
purifying
dalton
antigenic protein
protein
Prior art date
Application number
AT90120662T
Other languages
German (de)
Inventor
John William Gotto
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE137976T1 publication Critical patent/ATE137976T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A process for extracting and purifying a protein having an apparent molecular weight of about 69,000 daltons from the outer membrane of the bacterium Bordetella pertussis is provided. The process includes inactivating Bordetella pertussis cells with a bacteriostatic agent, repetitive extraction, and purification of the 69,000 dalton protein from extract by dye ligand chromatography followed by chromatofocusing. The process results in improved yield and stability of the 69,000 dalton protein.
AT90120662T 1989-12-11 1990-10-29 METHOD FOR PURIFYING A 69000 DALTON ANTIGENIC PROTEIN FROM BORDETELLA PERTUSSIS ATE137976T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/448,777 US5276142A (en) 1989-12-11 1989-12-11 Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis

Publications (1)

Publication Number Publication Date
ATE137976T1 true ATE137976T1 (en) 1996-06-15

Family

ID=23781640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90120662T ATE137976T1 (en) 1989-12-11 1990-10-29 METHOD FOR PURIFYING A 69000 DALTON ANTIGENIC PROTEIN FROM BORDETELLA PERTUSSIS

Country Status (13)

Country Link
US (1) US5276142A (en)
EP (1) EP0437687B1 (en)
JP (1) JP2950970B2 (en)
KR (1) KR0180527B1 (en)
AT (1) ATE137976T1 (en)
AU (1) AU641711B2 (en)
CA (1) CA2031763A1 (en)
DE (1) DE69027013T2 (en)
DK (1) DK0437687T3 (en)
ES (1) ES2087109T3 (en)
FI (1) FI101380B (en)
NO (1) NO301717B1 (en)
SG (1) SG54177A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US6444211B2 (en) 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9304399D0 (en) * 1993-03-04 1993-04-21 Smithkline Beecham Biolog Novel process
ATE183194T1 (en) * 1994-04-28 1999-08-15 Takeda Chemical Industries Ltd METHOD FOR SEPARATING PROTECTIVE COMPOUNDS FROM BORDETELLA PERTUSSIS
DE19512346C1 (en) * 1995-04-01 1996-06-13 Behringwerke Ag Procedure for cleaning filament hemagglutinin and pertussis toxin
US5877298A (en) * 1995-05-04 1999-03-02 Connaught Lab Acellular pertussis vaccines and methods of preparing thereof
EP0824358B1 (en) 1995-05-04 2002-12-04 Aventis Pasteur Limited Acellular pertussis vaccines and methods of preparation thereof
GB9611501D0 (en) * 1996-06-03 1996-08-07 Smithkline Beecham Biolog Vaccine compositions
DK0914153T3 (en) 1996-07-02 2007-01-29 Sanofi Pasteur Ltd Multivalent DTP polio vaccines
WO2010131111A1 (en) * 2009-05-11 2010-11-18 Novartis Ag Antigen purification process for pertactin antigen
CN102584958A (en) * 2012-02-08 2012-07-18 北京天坛生物制品股份有限公司 Purification method for 69KD outer membrane protein of pertussis bacillus
EA030749B1 (en) 2013-03-08 2018-09-28 Янссен Вэксинс Энд Превеншн Б.В. Acellular pertussis vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8512972D0 (en) * 1985-05-22 1985-06-26 Univ Glasgow Vaccine production
NZ226333A (en) * 1987-09-28 1991-09-25 Beecham Inc Inactivated viral or bacterial vaccine using ascorbic acid, oxygen and heavy metal ions as inactivating agents
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis

Also Published As

Publication number Publication date
US5276142A (en) 1994-01-04
FI101380B1 (en) 1998-06-15
AU6793390A (en) 1991-06-13
DK0437687T3 (en) 1996-06-03
AU641711B2 (en) 1993-09-30
EP0437687A3 (en) 1991-07-31
CA2031763A1 (en) 1991-06-12
KR0180527B1 (en) 1999-04-01
NO905324L (en) 1991-06-12
EP0437687B1 (en) 1996-05-15
NO905324D0 (en) 1990-12-10
ES2087109T3 (en) 1996-07-16
FI906071A0 (en) 1990-12-10
DE69027013D1 (en) 1996-06-20
KR910012234A (en) 1991-08-07
EP0437687A2 (en) 1991-07-24
DE69027013T2 (en) 1996-12-19
NO301717B1 (en) 1997-12-01
JPH03191789A (en) 1991-08-21
FI101380B (en) 1998-06-15
SG54177A1 (en) 1998-11-16
FI906071L (en) 1991-06-12
JP2950970B2 (en) 1999-09-20

Similar Documents

Publication Publication Date Title
ATE137976T1 (en) METHOD FOR PURIFYING A 69000 DALTON ANTIGENIC PROTEIN FROM BORDETELLA PERTUSSIS
ATE32102T1 (en) PROCESS FOR EXTRACTING POLY-BETAHYDROXYBUTYRATES FROM AN AQUEOUS SUSPENSION OF MICROORGANISMS USING A SOLVENT.
FI901646A0 (en) Crystalline 2-O-D-glucopyranosyl-L-ascorbic acid and process for its preparation
ATE192486T1 (en) CHONDROITINASE, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITION
DE69007854D1 (en) Process and apparatus for producing an oxide superconducting wire.
ATE122054T1 (en) METHOD FOR PRODUCING AN INTRAVENOUSLY TOLERABLE IMMUNOGLOBULIN G PREPARATION.
DE3667489D1 (en) METHOD FOR PRODUCING A PROTEIN.
FR2630438B1 (en) NOVEL P-PHENYLENEDIAMINES, PROCESS FOR THEIR PREPARATION, TINCTORIAL COMPOSITION CONTAINING THEM AND DYEING METHOD THEREOF
IL79972A0 (en) Protein recovery
DE69010117D1 (en) METHOD FOR SIMPLY RECOVERING AN ADSORBLE GAS FROM A GAS CONTAINING THE ADDIBLE GAS IN LOW CONCENTRATION.
ATE154033T1 (en) METHOD FOR PURIFYING PROTEINS
DE3678781D1 (en) METHOD FOR PRODUCING A POROUS MEMBRANE FOR SEPARATING BLOOD COMPONENTS.
DE3768720D1 (en) METHOD FOR SEPARATING AMINO ACIDS.
DE3788352D1 (en) METHOD FOR PRODUCING A HETEROLOGICAL PROTEIN IN INSECT CELLS.
DE69112750D1 (en) Process for obtaining teicoplanin.
FR2597344B1 (en) IMPROVEMENT IN THE PROCESS OF PURIFYING PROTEIN ANTIGENS FROM BACTERIA BELONGING TO THE GENUS BORDETELLA, WITH A VIEW TO OBTAINING A CELLULAR VACCINE.
PT95789A (en) METHOD FOR INSULATING AND PURIFYING ANTIGENIC FACTORS OF BORDETELLA PERTUSSIS
DE3766342D1 (en) METHOD FOR PRODUCING AN AETHYLENE-PROPYLENE-COPOLYMER RUBBER.
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
DE69111838D1 (en) Process for the preparation of (per) fluoropolyethers of a controllable molecular weight.
AT384032B (en) METHOD FOR PRODUCING POLYDISPERSE NATIVE PSEUDOMONAS-FLAGELLA (H) -ANTIGENS (FAG)
DE68917709D1 (en) Process for the preparation of a pertussis toxin toxoid.
DE3874468D1 (en) METHOD FOR PRODUCING A JASMINE EXTRACT AND THE EXTRACT SO OBTAINED.
ATE123001T1 (en) METHOD FOR SEPARATING YTTRIUM.
DE3786947D1 (en) MICROBIOLOGICAL METHOD FOR OBTAINING A PROTEIN BY BREEDING A MUTANT BACTERIA.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee